In the world there are close to 25 million people living with cancer today, a figure that will probably increase to around 30 million people by 2020 .This publication is one of the most extensive studies of novel concepts for fighting cancer.
Scope of this report
Global cancer trends
Global pipeline overview and clinical trial analysis
Current treatment of major cancer indications
Strategy and progress on new anticancer targets and drugs
Evolving screening technologies
Research and analysis highlights
There are, at present, ten times more anticancer drugs being tested in clinical trials than there were 20 years ago. Many of the new classes of agents, however, are predicted to work in only small subpopulations of patients, target unconventional aspects of tumour development and interact with other agents in an unpredictable manner. How can research and clinical trials be re-designed to accommodate the new features of targeted anticancer drugs? This publication reports on more than 100 companies and close to a 100 different anticancer drugs, where of 20 are new to the world in general.
Key reasons to read this report
Find out where the cancer market is going
Current status on drugs available to fight major cancer indications
Discover the very latest about new innovative anticancer drugs, and how they are made
